SGCE mutations cause psychiatric disorders: Clinical and genetic characterization

Brain

Volumn 136, Issue 1, 2013, Pages 294-303

  Peall, Kathryn J ^a   Smith, Daniel J ^a   Kurian, Manju A ^b   Wardle, Mark ^a   Waite, Adrian J ^a   Hedderly, Tammy ^c   Lin, Jean Pierre ^c   Smith, Martin ^d   Whone, Alan ^e   Pall, Hardev ^f   White, Cathy ^g   Lux, Andrew ^h   Jardine, Philip ^h   Bajaj, Narinder ⁱ   Lynch, Bryan ^j   Kirov, George ^a   O'Riordan, Sean ^k   Samuel, Michael ^l,m   Lynch, Timothy ⁿ   King, Mary D ^j   Chinnery, Patrick F ^o   Warner, Thomas T ^p   Blake, Derek J ^a   Owen, Michael J ^a   Morris, Huw R ^a   more..

^a CARDIFF UNIVERSITY   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^e FRENCHAY HOSPITAL   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g SINGLETON HOSPITAL   (United Kingdom)

^h BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^k ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^l EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^m KING'S COLLEGE LONDON   (United Kingdom)

ⁿ MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^o NEWCASTLE UNIVERSITY   (United Kingdom)

^p UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

myoclonus dystonia; psychiatric disorders; SGCE

Indexed keywords

ALCOHOL; EPSILON SARCOGLYCAN;

ADULT; AGORAPHOBIA; ALCOHOLISM; ARTICLE; COMPULSION; CONTROL GROUP; DISABILITY; FEMALE; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENERALIZED ANXIETY DISORDER; GENETIC ANALYSIS; HUMAN; HYPOMANIA; INTERVIEW; IRELAND; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MENTAL DISEASE; MYOCLONUS DYSTONIA; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL PHOBIA; TREMOR; UNITED KINGDOM;

EID: 84873359706     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws308     Document Type: Article

References (69)

1. Asmus F, Zimprich A, Tezenas Du Montcel S, Kabus C, Deuschl G, Kupsch A, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 2002; 52: 489-92.
2. Asmus F, Salih F, Hjermind LE, Ostergaard K, Munz M, Kühn AA, et al. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann Neurol 2005; 58: 792-7.
3. Asmus F, Hjermind LE, Dupont E, Wagenstaller J, Haberlandt E, Munz M, et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007; 130: 2736-45.
4. Asmus F, Langseth A, Doherty E, Nestor T, Munz M, Gasser T, et al. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Mov Disord 2009; 24: 702-9.
5. Azoulay-Zyss J, Roze E, Welter ML, Navarro S, Yelnik J, Clot F, et al. Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch Neurol 2011; 68: 94-8.
6. Barahona-Correa B, Bugalho P, Guimaraes J, Xavier M. Obsessive-compulsive symptoms in primary focal dystonia: a controlled study. Mov Disord 2011; 26: 2274-8.
7. Beukers RJ, Foncke EM, van der Meer JN, Veltman DJ, Tijssen MA. Functional magnetic resonance imaging evidence of incomplete maternal imprinting in myoclonus-dystonia. Arch Neurol 2011a; 68: 802-5.
8. Beukers RJ, van der Meer JN, van der Salm SM, Foncke EM, Veltman DJ, Tijssen MA. Severity of dystonia is correlated with putaminal gray matter changes in myoclonus-dystonia. Eur J Neurol 2011b; 18: 906-12.
9. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dys-trophin and dystrophin-related proteins in muscle. Physiol Rev 2002; 82: 291-329.
10. Breiter HC, Rauch SL. Functional MRI and the study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 1996; 4: S127-38.
11. Broocks A, Thiel A, Angerstein D, Dressler D. Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm. Am J Psychiatry 1998; 155: 555-7.
12. Burke RE, Fahn S, Marsden CD, Bressman SB, Moskowitz C, Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 1985; 35: 73-7.
13. Caetano R. Alcohol dependence and the need to drink: a compulsion? Psychol Med 1985; 15: 463-9.
14. Cavallaro R, Galardi G, Cavallini MC, Henin M, Amodio S, Bellodi L, et al. Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry 2002; 52: 356-61.
15. Chen XP, Zhang YW, Zhang SS, Chen Q, Burgunder JM, Wu SH, et al. A novel mutation of the epsilon-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome. Mov Disord 2008; 23: 1472-5.
16. Chung EJ, Lee WY, Kim JY, Kim JH, Kim GM, Ki CS, et al. Novel SGCE gene mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya-Moya disease. Mov Disord 2007; 22: 1206-7.
17. Dale RC, Nasti JJ, Peters GB. Familial 7q21.3 microdeletion involving epsilon-sarcoglycan causing myoclonus dystonia, cognitive impairment, and psychosis. Mov Disord 2011; 26: 1774-5.
18. DeBerardinis RJ, Conforto D, Russell K, Kaplan J, Kollros PR, Zackai EH, et al. Myoclonus in a patient with a deletion of the epsilon-sarcoglycan locus on chromosome 7q21. Am J Med Genet A 2003; 121A: 31-6.
19. Doheny DO, Brin MF, Morrison CE, Smith CJ, Walker RH, Abbasi S, et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002; 59: 1187-96.
20. Douglass HM, Moffitt TE, Dar R, McGee R, Silva P. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry 1995; 34: 1424-31.
21. Duane DD. Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology 2005; 64: 1821-2; author reply 1821-2.
22. Esapa CT, Waite A, Locke M, Benson MA, Kraus M, McIlhinney RA, et al. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum Mol Genet 2007; 16: 327-42.
23. Fabbrini G, Berardelli I, Moretti G, Pasquini M, Bloise M, Colosimo C, et al. Psychiatric disorders in adult-onset focal dystonia: a case-control study. Mov Disord 2010; 25: 459-65.
24. Foncke EM, Cath D, Zwinderman K, Smit J, Schmand B, Tijssen M. Is psychopathology part of the phenotypic spectrum of myoclonus-dystonia?: a study of a large Dutch M-D family. Cogn Behav Neurol 2009; 22: 127-33.
25. Frucht SJ, Leurgans SE, Hallett M, Fahn S. The unified myoclonus rating scale. Adv Neurol 2002; 89: 361-76.
26. Fullana MA, Mataix-Cols D, Caspi A, Harrington H, Grisham JR, Moffitt TE, et al. Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. Am J Psychiatry 2009; 166: 329-36.
27. Gerrits MC, Foncke EM, de Haan R, Hedrich K, van de Leemput YL, Baas F, et al. Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 2006; 66: 759-61.
28. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989a; 46: 1012-16.
29. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989b; 46: 1006-11.
30. Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, Gasser T, et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003; 11: 138-44.
31. Grimes DA, Bulman D, George-Hyslop PS, Lang AE. Inherited myoclonus-dystonia: evidence supporting genetic heterogeneity. Mov Disord 2001; 16: 106-10.
32. Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, Bulman DE. A novel locus for inherited myoclonus-dystonia on 18p11. Neurology 2002; 59: 1183-6.
33. Gruber D, Kühn AA, Schoenecker T, Kivi A, Trottenberg T, Hoffmann KT, et al. Pallidal and thalamic deep brain stimulation in myoclonus-dystonia. Mov Disord 2010; 25: 1733-43.
34. Grunewald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 2008; 29: 331-2.
35. Guettard E, Portnoi MF, Lohmann-Hedrich K, Keren B, Rossignol S, Winkler S, et al. Myoclonus-dystonia due to maternal uniparental disomy. Arch Neurol 2008; 65: 1380-5.
36. Gündel H, Wolf A, Xidara V, Busch R, Ceballos-Baumann AO. Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry 2001; 71: 499-504.
37. Gündel H, Wolf A, Xidara V, Busch R, Ladwig KH, Jacobi F, et al. High psychiatric comorbidity in spasmodic torticollis: a controlled study. J Nerv Ment Dis 2003; 191: 465-73.
38. Heiman GA, Ottman R, Saunders-Pullman RJ, Ozelius LJ, Risch NJ, Bressman SB. Obsessive-compulsive disorder is not a clinical manifestation of the DYT1 dystonia gene. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 361-4.
39. Hess CW, Raymond D, Aguiar Pde C, Frucht S, Shriberg J, Heiman GA, et al. Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers. Neurology 2007; 68: 522-4.
40. Hubsch C, Vidailhet M, Rivaud-Péchoux S, Pouget P, Brochard V, Degos B, et al. Impaired saccadic adaptation in DYT11 dystonia. J Neurol Neurosurg Psychiatry 2011; 82: 1103-6.
41. Kessler RC, Gonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8-19.
42. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.
43. Lauterbach EC, Spears TE, Prewett MJ, Price ST, Jackson JG, Kirsh AD. Neuropsychiatric disorders, myoclonus, and dystonia in calcification of basal ganglia pathways. Biol Psychiatry 1994; 35: 345-51.
44. Lencer R, Steinlechner S, Stahlberg J, Rehling H, Orth M, Baeumer T, et al. Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles. J Neurol Neurosurg Psychiatry 2009; 80: 1176-9.
45. Marechal L, Raux G, Dumanchin C, Lefebvre G, Deslandre E, Girard C, et al. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation. Am J Med Genet B Neuropsychiatr Genet 2003; 119B: 114-17.
46. Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Mov Disord 2007; 22: 1173-5.
47. Modell JG, Glaser FB, Cyr L, Mountz JM. Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcohol Clin Exp Res 1992; 16: 272-4.
48. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9.
49. Muller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, et al. Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 2002; 71: 1303-11.
50. Nardocci N, Zorzi G, Barzaghi C, Zibordi F, Ciano C, Ghezzi D, et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 2008; 23: 28-34.
51. Peall KJ, Waite AJ, Blake DJ, Owen MJ, Morris HR. Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review. Mov Disord 2011; 26: 1939-42.
52. Playford ED, Passingham RE, Marsden CD, Brooks DJ. Increased activation of frontal areas during arm movement in idiopathic torsion dys-tonia. Mov Disord 1998; 13: 309-18.
53. Raymond D, Saunders-Pullman R, de Carvalho Aguiar P, Schule B, Kock N, Friedman J, et al. Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutations. Mov Disord 2008; 23: 588-92.
54. Ritz K, Gerrits MC, Foncke EM, van Ruissen F, van der Linden C, Vergouwen MD, et al. Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry 2009; 80: 653-8.
55. Roze E, Apartis E, Clot F, Dorison N, Thobois S, Guyant-Marechal L, Tranchant C, et al. Myoclonus-dystonia: clinical and electro-physiologic pattern related to SGCE mutations. Neurology 2008; 70: 1010-16.
56. Saugier-Veber P, Doummar D, Barthez MA, Czernecki V, Drouot N, Apartis E, et al. Myoclonus dystonia plus syndrome due to a novel 7q21 microdeletion. Am J Med Genet A 2010; 152A: 1244-9.
57. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88: 791-804.
58. Saunders-Pullman R, Ozelius L, Bressman SB. Inherited myoclonus-dystonia. Adv Neurol 2002a; 89: 185-91.
59. Saunders-Pullman R, Shriberg J, Heiman G, Raymond D, Wendt K, Kramer P, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002b; 58: 242-5.
60. Scheidt CE, Waller E, Schnock C, Becker-Stoll F, Zimmermann P, Lü cking CH, et al. Alexithymia and attachment representation in idiopathic spasmodic torticollis. J Nerv Ment Dis 1999; 187: 47-52.
61. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (Suppl 20): 22-33; quiz 34-57.
62. Tezenas du Montcel S, Clot F, Vidailhet M, Roze E, Damier P, Jedynak CP, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 2006; 43: 394-400.
63. Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, Salvi S, et al. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity. Mov Disord 2003; 18: 1047-51.
64. Valente EM, Edwards MJ, Mir P, DiGiorgio A, Salvi S, Davis M, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 2005; 64: 737-9.
65. WaiteA, Tinsley CL, Locke M, Blake DJ. The neurobiologyofthe dystrophin-associated glycoprotein complex. Ann Med 2009; 41: 344-59.
66. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
67. Wenzel T, Schnider P, Wimmer A, Steinhoff N, Moraru E, Auff E. Psychiatric comorbidity in patients with spasmodic torticollis. J Psychosom Res 1998; 44: 687-90.
68. Wong SH, Steiger MJ, Larner AJ, Fletcher NA. Hereditary myoclonus dystonia (DYT11): a novel SGCE gene mutation with intrafamilial phenotypic heterogeneity. Mov Disord 2010; 25: 956-7.
69. Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001; 29: 66-9.